Mydecine Speaker Series II - Microdosing: A Pathway to psilocybin mental health treatment

Memo

Microdose Psychedelic Insights invites you to join the Mydecine Speaker Series, dedicated to the exploration of the incredible findings around the current psychedelic research and what the path to mainstream acceptance looks like. Mydecine Speaker Series II - Microdosing: A Pathway to psilocybin mental health treatment starts on Thursday Jan 21st 2021 2pm - 3:30pm EST hosted by Mydecine Innovations Group Inc. moderated by Elie Dolgin Ph.D. This panel will discuss the benefits and challenges of Microdosing with some of the world's top scientists. Panelists Robert Roscow, MA, Mydecine, Chief Scientific Officer and Co-Founder, Vince Polito, Ph.D. Cognitive Science Researcher at Macquarie University, Australia, David Erritzoe, MD, Ph.D., MRCPsych NIHR Academic Clinical Lecturer in General Psychiatry in Neuropsychopharmacology and Psychedelic Research Centres, Division of Psychiatry, Dpt of Brain Sciences, Imperial College London, moderated by Elie Dolgin Ph.D. a freelance science journalist. URL:Tickets: https://go.evvnt.com/728139-1?pid=5569 Price:Free: CAD 0.00 Time: 2:00 pm to 3:30 pm